{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-25-011885","form_type":"8-K","ticker":"IBIO","cik":"0001420720","company_name":"iBio, Inc.","filed_at":"2025-09-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.951186+00:00","generated_at":"2026-05-17T07:55:32.540185+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"iBio FY2025 revenue $0.4M, cash $8.8M; advances obesity pipeline with IBIO-610 fat loss data","bullets":["Revenue $0.4M (up $0.2M YoY); R&D expense $8.3M (+$3.1M); G&A $10.7M (-$1.0M).","Cash $8.8M at June 30; raised $6.2M warrant inducement; closed $50M public offering (potential +$50M on warrant exercise).","IBIO-610 (activin E) showed 26% fat mass reduction with no lean mass loss in mice; NHP study initiated.","IBIO-600 (anti-myostatin) NHP PK data demonstrated extended half-life and dose-dependent muscle growth.","Collaboration with AstralBio yielded amylin receptor antibody reducing acute food intake 60% in obese mice."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-25-011885","json":"https://secwatch.observer/filing/0001558370-25-011885.json","markdown":"https://secwatch.observer/filing/0001558370-25-011885.md","text":"https://secwatch.observer/filing/0001558370-25-011885.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1420720/000155837025011885/0001558370-25-011885-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1420720/000155837025011885/ibio-20250905x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T07:55:32.540185+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}